Lasalocid

DB11423ExperimentalVet approvedSmall molecule

Lasalocid is an agent that presents antibacterial and coccidiostat activities. It is produced by strains of Streptomyces lasaliensis.

Formula / weight: C₃₄H₅₄O₈ · 590.798 g/mol (avg)
Code names: RO 2-2985

Resolves to

Compound

UNIIW7V2ZZ2FWBCAS25999-31-9ChEMBLCHEMBL145347ChEBI92181KEGGD04671

Clinical / RWD

RxNorm1364397

Structure

InChIKeyBBMULGJBVDDDNI-OWKLGTHSSA-NSMILES

[H][C@@](C)(CCC1=C(C(O)=O)C(O)=C(C)C=C1)[C@]([H])(O)[C@]([H])(C)C(=O)[C@]([H])(CC)[C@@]1([H])O[C@@](CC)(C[C@]1([H])C)[C@@]1([H])CC[C@](O)(CC)[C@]([H])(C)O1

Targets

P80365HSD11B2P12931SRCO14983ATP2A1

What you can answer from here — as of July 07, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

56Drug interactionsStructured to mechanism, not free text

13+ReferencesStructured and connected to the statements they support

Which drugs share a target with Lasalocid, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account